Company overview
IKA provides innovative laboratory equipment including magnetic stirrers, overhead stirrers, shakers, homogenizers, mills, rotary evaporators, and reactors for research and development in life sciences and pharma. These solutions support mixing, heating, distilling, crushing, and process optimization, enhancing efficiency, reproducibility, and compliance in laboratories. IKA serves global customers like BASF and Bayer with state-of-the-art tools for the process industry.
Ika England Ltd is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include ika lab equipment, laboratory stirrers, pharma reactors, homogenizers, rotary evaporators.
Products and technologies associated with Ika England Ltd include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.ika.com
- Markets served
- United States & Americas
- Keywords
- ika lab equipment, laboratory stirrers, pharma reactors, homogenizers, rotary evaporators
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What laboratory equipment does IKA offer for pharma R&D?
- IKA offers magnetic stirrers, mixers, overhead stirrers, shakers, homogenizers, mills, rotary evaporators, reactors, and calorimeters for applications in mixing, heating, distilling, and crushing.
- What are the key capabilities of IKA reactors?
- IKA laboratory reactors save time and resources, provide greater flexibility in production, improve material quality, and reduce response and breakdown times for research laboratories.
- Where does IKA operate and serve customers?
- IKA has over 800 employees at eight locations on four continents, with a UK office in Oxford, and serves global pharma leaders like BASF, Bayer, and Procter & Gamble, including support for African laboratories.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
